• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG Back to Search Results
Catalog Number 07P51-20
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/16/2020
Event Type  malfunction  
Manufacturer Narrative
There was no further patient information provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7p51-20 that has a similar product distributed in the us, list number 7p51-21.
 
Event Description
The customer reported false positive alinity i b-hcg results on one patient.The results provided were: on (b)(6) 2020 sid(b)(6) = 38.99iu/l (>/=25.00iu/l = positive) / retest on same tube = <2.30iu/l x2 (<5.00iu/l = negative) / new sample same patient = negative.There was no reported impact to patient management.
 
Manufacturer Narrative
The ticket search determined normal complaint activity for lot 06112ui00, and no trends were identified for the product.Return testing was not completed as returns were not available.Accuracy testing was performed with a retained kit of lot 06112ui00 and all validity and acceptance criteria were met, demonstrating that this lot is performing acceptably.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity i total b-hcg reagent, lot 06112ui00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TOTAL B-HCG
Type of Device
B-HCG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key9666977
MDR Text Key189562043
Report Number3005094123-2020-00032
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/24/2020
Device Catalogue Number07P51-20
Device Lot Number06112UI00
Was Device Available for Evaluation? No
Date Manufacturer Received03/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE, LN 03R65-01,; ALINITY I PROCESSING MODULE, LN 03R65-01,; SERIAL # (B)(6); SERIAL # (B)(6)
-
-